SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-016680
Filing Date
2020-08-25
Accepted
2020-08-25 16:38:50
Documents
49
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 332635
2 ex31-1.htm EX-31.1 13056
3 ex32-1.htm EX-32.1 7490
  Complete submission text file 0001493152-20-016680.txt   2312359

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lung-20200331.xml EX-101.INS 295945
5 XBRL SCHEMA FILE lung-20200331.xsd EX-101.SCH 42031
6 XBRL CALCULATION FILE lung-20200331_cal.xml EX-101.CAL 38650
7 XBRL DEFINITION FILE lung-20200331_def.xml EX-101.DEF 119265
8 XBRL LABEL FILE lung-20200331_lab.xml EX-101.LAB 272547
9 XBRL PRESENTATION FILE lung-20200331_pre.xml EX-101.PRE 194886
Mailing Address 350 W. 800 N. SUITE 214 SALT LAKE CITY UT 84103
Business Address 350 W. 800 N. SUITE 214 SALT LAKE CITY UT 84103 (801) 736-0729
PROLUNG INC (Filer) CIK: 0001541884 (see all company filings)

IRS No.: 201922768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38362 | Film No.: 201132699
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences